SANGAMO THERAPEUTICS, INC Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 25,000 | |
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.23 | 25,000 | 280,843 | 295,000 | 320 K to 295 K (-7.81 %) |
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 11.37 | 2,000 | 22,748 | 213,353 | 215.4 K to 213.4 K (-0.93 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 4.10 | 10,000 | 41,000 | 0 | |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.00 | 10,000 | 120,007 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 4.10 | 10,000 | 41,000 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 8,202 | 55,938 | 41,798 | |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 6,798 | 27,940 | 0 | |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.35 | 15,000 | 170,258 | 97,856 | 112.9 K to 97.9 K (-13.29 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 8,202 | 55,938 | 112,856 | 104.7 K to 112.9 K (+7.84 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 6,798 | 27,940 | 104,654 | 97.9 K to 104.7 K (+6.95 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 5,000 | 28,500 | 65,172 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 55,000 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 37,500 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 2,000 | 13,640 | 0 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 11.91 | 15,000 | 178,704 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 5,000 | 28,500 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 119,347 | 114.3 K to 119.3 K (+4.37 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 114,347 | 111.3 K to 114.3 K (+2.69 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 2,000 | 13,640 | 111,347 | 109.3 K to 111.3 K (+1.83 %) |